Stoneridge Investment Partners’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-17,932
Closed -$71K 174
2026
Q1
$71K Hold
17,932
0.05% 122
2025
Q4
$121K Buy
17,932
+3,871
+28% +$27.1K 0.08% 114
2025
Q3
$98K Buy
14,061
+1,187
+9% +$8.25K 0.07% 112
2025
Q2
$79K Buy
+12,874
New +$85.6K 0.06% 113

Other funds holding MDXG

Stoneridge Investment Partners's MDXG Position: Q2 2026 in Review

Stoneridge Investment Partners sold out of MiMedx Group (MDXG) in Q2 2026, closing a stake of 17,932 shares — an estimated $71K sold.

Stoneridge Investment Partners first reported a position in MDXG in Q2 2025 and held it in 4 quarters. The position peaked at $121K in Q4 2025. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Stoneridge Investment Partners reported no remaining MiMedx Group position as of Q2 2026 after selling out during the quarter.
  • Stoneridge Investment Partners sold 17,932 MiMedx Group shares in Q2 2026, an estimated $71K.
  • Stoneridge Investment Partners first reported a position in MiMedx Group in Q2 2025 and held it in 4 quarters.
  • Stoneridge Investment Partners's MiMedx Group position peaked at $121K in Q4 2025.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Stoneridge Investment Partners's 13F filing for Q2 2026, filed 6 Aug 2026.